Table 3.

Clinical Outcomes in LAD-Deferred Patients

	Unadjusted				Adjusted
	iFR Group (n = 451)	FFR Group (n = 421)	Hazard Ratio (95% CI)	p Value	Hazard Ratio (95% CI)	p Value
MACE (cardiovascular death, MI, unplanned revascularization)	11 (2.44)	23 (5.46)	0.47 (0.23–0.96)	0.04∗	0.46 (0.22–0.95)	0.04∗
Cardiovascular death	0 (0.00)	1 (0.24)
MACE (all-cause death, MI, unplanned revascularization)	15 (3.33)	27 (6.41)	0.54 (0.29–1.02)	0.06	0.53 (0.28–1.01)	0.05
All-cause death	4 (0.89)	5 (1.19)	0.76 (0.21–2.84)	0.69	0.77 (0.21–2.86)	0.69
MI	2 (0.44)	9 (2.14)	0.24 (0.05–1.11)	0.07	0.23 (0.05–1.07)	0.06
Target vessel MI	1 (0.22)	6 (1.43)	0.16 (0.02–1.30)	0.09	0.15 (0.02–1.23)	0.08
Nontarget vessel MI	0 (0.00)	2 (0.48)
Periprocedural MI	1 (0.22)	1 (0.24)	1.00 (1.00–1.00)	1.00	1.00 (1.00–1.00)	1.00
Unplanned revascularization	10 (2.22)	21 (4.99)	0.45 (0.21–0.95)	0.04∗	0.44 (0.21–0.93)	0.03∗
TVR	7 (1.55)	15 (3.56)	0.44 (0.18–1.07)	0.07	0.42 (0.17–1.04)	0.06
Non-TVR	3 (0.67)	6 (1.43)	0.47 (0.12–1.88)	0.29	0.47 (0.12–1.88)	0.28

Values are n (%) unless otherwise indicated.

CI = confidence interval; MACE = major adverse cardiac events; MI = myocardial infarction; TVR = target vessel revascularization; other abbreviations as in Table 1.

^∗Statistically significant p values.